+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Multiplex Assays Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4851850
  • Report
  • November 2018
  • Region: Global
  • 333 pages
  • Transparency Market Research
1 of 2

Global Multiplex Assays Market: Overview

The global multiplex assays market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, technology, type, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by geography and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global multiplex assays market.

Global Multiplex Assays Market: Key Segments

In terms of product, the global multiplex assays market has been segmented into instruments, consumables, and software. The consumables segment has been further categorized into reagents & kits, micropipettes and microplates, and others. Expansion of the consumables segment is primarily due to repeat orders for reagents and kits. Additionally, the market has been segmented based on technology, type, and application.

Based on end-user, the global multiplex assays market has been classified into biotechnology & biopharmaceutical companies, academic & research centers, diagnostic centers, hospitals, and others. The biotechnology & biopharmaceutical companies segment is anticipated to expand at a significant CAGR during the forecast period. The market has been analyzed based on price variations, technology trend, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Multiplex Assays Market: Regional Outlook

In terms of region, the global multiplex assays market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key companies profiled in the global multiplex assays market include Luminex Corporation, Thermo Fisher Scientific, Inc., Seegene, Inc., Meso Scale Diagnostics, LLC., Abcam plc, Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Quansys Biosciences, and Illumina, Inc.

The global multiplex assays market has been segmented as follows:

Global Multiplex Assays Market, by Product

  • Instruments
  • Consumables
    • Reagents & Kits
    • Micropipettes & Microplates
    • Others
  • Software

Global Multiplex Assays Market, by Technology

  • Multiplex RT-PCR
  • Flow Cytometry
  • Luminescence
  • Fluorescence
  • Others

Global Multiplex Assays Market, by Type

  • Protein
    • Planar
    • Bead-based
  • Nucleic Acid
    • Planar
    • Bead-based
  • Cell

Global Multiplex Assays Market, by Application

  • Research & Development
    • Drug Discovery & Research
    • Biomarker Research & Application
  • Diagnosis
    • Infectious Diseases
    • Autoimmune Diseases
    • Cancer
    • Cardiovascular Diseases
    • Neuro-endocrine Diseases
    • Others
  • Others

Global Multiplex Assays Market, by End-user

  • Biotechnology & Biopharmaceutical Companies
  • Academic & Research Centers
  • Diagnostic Centers
  • Hospitals
  • Others

Global Multiplex Assays Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Acronyms Used

3. Research Methodology

4. Executive Summary

5. Market Overview
5.1. Product Overview
5.2. Market Dynamics
5.2.1. Drivers
5.2.1.1. Advantages of multiplex assays over singleplex assays
5.2.1.2. Government and non-government funding
5.2.1.3. Rise in prevalence of infectious diseases and cancer
5.2.1.4. Strategic acquisitions and partnerships
5.2.1.5. Increasing applications of multiplex assays
5.2.1.6. Significant product launches
5.2.2. Restraints
5.2.2.1. Lack of skilled labor
5.2.2.2. High cost of multiplex assay systems
5.2.2.3. Constraints of multiplex assays
5.2.2.4. Stringent regulatory environment
5.2.2.5. Product recalls
5.2.3. Opportunities
5.2.3.1. Rise in focus on multiplexed point-of-care testing
5.2.3.2. Combining multiplex assays with microchip arrays
5.2.4. Trends
5.2.4.1. Increase in the number of biotechnology companies
5.2.4.2. Growing need for personalized medicine
5.3. Global Multiplex Assays Market Value (US$ Mn) Forecast, 2016-2026
5.4. Global Multiplex Assays Market Outlook
5.5. Key Industry Developments
5.6. Porter's Five Forces Analysis
5.7. Comparative Analysis - Multiplex Assays vs Singleplex Assays
5.8. Comparative Analysis - Planar and Bead-based Multiplex Assays
5.9. Multiplex Assay - Steps Involved
5.10. Value Chain Analysis
5.11. Multiplex Assays - List of Distributors
5.12. Key Regulatory Agencies
5.13. Regulatory Approval Process
5.13.1. U.S.
5.13.2. Europe
5.13.3. Asia Pacific
5.13.4. Latin America
5.13.5. Middle East & Africa

6. Global Multiplex Assays Market Analysis, by Product
6.1. Introduction
6.2. Key Findings
6.3. Global Multiplex Assays Market Value Share Analysis, by Product
6.4. Global Multiplex Assays Market Value Forecast, by Product, 2016-2026
6.4.1. Instruments
6.4.2. Consumables
6.4.2.1. Reagents & Kits
6.4.2.2. Micropipettes & Microplates
6.4.2.3. Others
6.4.3. Software
6.5. Global Multiplex Assays Market Attractiveness, by Product

7. Global Multiplex Assays Market Analysis, by Technology
7.1. Introduction
7.2. Key Findings
7.3. Global Multiplex Assays Market Value Share Analysis, by Technology
7.4. Global Multiplex Assays Market Value Forecast, by Technology, 2016-2026
7.4.1. Multiplex RT-PCR
7.4.2. Flow Cytometry
7.4.3. Luminescence
7.4.4. Fluorescence
7.4.5. Others
7.5. Global Multiplex Assays Market Attractiveness, by Technology

8. Global Multiplex Assays Market Analysis, by Type
8.1. Introduction
8.2. Key Findings
8.3. Global Multiplex Assays Market Value Share Analysis, by Type
8.4. Global Multiplex Assays Market Value Forecast, by Type, 2016-2026
8.4.1. Protein
8.4.1.1. Planar
8.4.1.2. Bead-based
8.4.2. Nucleic Acid
8.4.2.1. Planar
8.4.2.2. Bead-based
8.4.3. Cell
8.5. Global Multiplex Assays Market Attractiveness, by Type

9. Global Multiplex Assays Market Analysis, by Application
9.1. Introduction
9.2. Key Findings
9.3. Global Multiplex Assays Market Value Share Analysis, by Application
9.4. Global Multiplex Assays Market Value Forecast, by Application, 2016-2026
9.4.1. Research & Development
9.4.1.1. Drug Discovery & Research
9.4.1.2. Biomarker Research & Application
9.4.2. Diagnosis
9.4.2.1. Infectious Diseases
9.4.2.2. Autoimmune Diseases
9.4.2.3. Cancer
9.4.2.4. Cardiovascular Diseases
9.4.2.5. Neuro-endocrine Diseases
9.4.2.6. Others
9.4.3. Others
9.5. Global Multiplex Assays Market Attractiveness, by Application

10. Global Multiplex Assays Market Analysis, by End-user
10.1. Introduction
10.2. Key Findings
10.3. Global Multiplex Assays Market Value Share Analysis, by End-user
10.4. Global Multiplex Assays Market Value Forecast, by End-user, 2016-2026
10.4.1. Academic & Research Centers
10.4.2. Biotechnology & Biopharmaceutical Companies
10.4.3. Diagnostic Centers
10.4.4. Hospitals
10.4.5. Others
10.5. Global Multiplex Assays Market Attractiveness, by End-user

11. Global Multiplex Assays Market Analysis and Forecasts, by Region
11.1. Introduction
11.2. Regional Outlook
11.3. Global Multiplex Assays Market Value Forecast, by Region, 2016-2026
11.3.1. North America
11.3.2. Europe
11.3.3. Asia-Pacific
11.3.4. Latin America
11.3.5. Middle East & Africa
11.4. Global Multiplex Assays Market Attractiveness Analysis, by Region

12. North America Multiplex Assays Market Analysis
12.1. Key Findings
12.2. North America Multiplex Assays Market Value Forecast by Country, 2016-2026
12.2.1. U.S.
12.2.2. Canada
12.3. North America Multiplex Assays Market Value Forecast, by Product, 2016-2026
12.3.1. Instruments
12.3.2. Consumables
12.3.2.1. Reagents & Kits
12.3.2.2. Micropipettes & Microplates
12.3.2.3. Others
12.3.3. Software
12.4. North America Multiplex Assays Market Value Forecast, by Technology, 2016-2026
12.4.1. Multiplex RT-PCR
12.4.2. Flow Cytometry
12.4.3. Luminescence
12.4.4. Fluorescence
12.4.5. Others
12.5. North America Multiplex Assays Market Value Forecast, by Type, 2016-2026
12.5.1. Protein
12.5.1.1. Planar
12.5.1.2. Bead-based
12.5.2. Nucleic Acid
12.5.2.1. Planar
12.5.2.2. Bead-based
12.5.3. Cell
12.6. North America Multiplex Assays Market Value Forecast, by Application, 2016-2026
12.6.1. Research & Development
12.6.1.1. Drug Discovery & Research
12.6.1.2. Biomarker Research & Application
12.6.2. Diagnosis
12.6.2.1. Infectious Diseases
12.6.2.2. Autoimmune Diseases
12.6.2.3. Cancer
12.6.2.4. Cardiovascular Diseases
12.6.2.5. Neuro-endocrine Diseases
12.6.2.6. Others
12.6.3. Others
12.7. North America Multiplex Assays Market Value Forecast, by End-user, 2016-2026
12.7.1. Academic & Research Centers
12.7.2. Biotechnology & Biopharmaceutical Companies
12.7.3. Diagnostic Centers
12.7.4. Hospitals
12.7.5. Others
12.8. North America Multiplex Assays Market Attractiveness
12.8.1. By Country
12.8.2. By Product
12.8.3. By Technology
12.8.4. By Type
12.8.5. By Application
12.8.6. By End-user

13. Europe Multiplex Assays Market Analysis
13.1. Key Findings
13.2. Europe Multiplex Assays Market Value Forecast by Country, 2016-2026
13.2.1. Germany
13.2.2. U.K.
13.2.3. France
13.2.4. Italy
13.2.5. Spain
13.2.6. Rest of Europe
13.3. Europe Multiplex Assays Market Value Forecast, by Product, 2016-2026
13.3.1. Instruments
13.3.2. Consumables
13.3.2.1. Reagents & Kits
13.3.2.2. Micropipettes & Microplates
13.3.2.3. Others
13.3.3. Software
13.4. Europe Multiplex Assays Market Value Forecast, by Technology, 2016-2026
13.4.1. Multiplex RT-PCR
13.4.2. Flow Cytometry
13.4.3. Luminescence
13.4.4. Fluorescence
13.4.5. Others
13.5. Europe Multiplex Assays Market Value Forecast, by Type, 2016-2026
13.5.1. Protein
13.5.1.1. Planar
13.5.1.2. Bead-based
13.5.2. Nucleic Acid
13.5.2.1. Planar
13.5.2.2. Bead-based
13.5.3. Cell
13.6. Europe Multiplex Assays Market Value Forecast, by Application, 2016-2026
13.6.1. Research & Development
13.6.1.1. Drug Discovery & Research
13.6.1.2. Biomarker Research & Application
13.6.2. Diagnosis
13.6.2.1. Infectious Diseases
13.6.2.2. Autoimmune Diseases
13.6.2.3. Cancer
13.6.2.4. Cardiovascular Diseases
13.6.2.5. Neuro-endocrine Diseases
13.6.2.6. Others
13.6.3. Others
13.7. Europe Multiplex Assays Market Value Forecast, by End-user, 2016-2026
13.7.1. Academic & Research Centers
13.7.2. Biotechnology & Biopharmaceutical Companies
13.7.3. Diagnostic Centers
13.7.4. Hospitals
13.7.5. Others
13.8. Europe Multiplex Assays Market Attractiveness
13.8.1. By Country
13.8.2. By Product
13.8.3. By Technology
13.8.4. By Type
13.8.5. By Application
13.8.6. By End-user

14. Asia Pacific Multiplex Assays Market Analysis
14.1. Key Findings
14.2. Asia Pacific Multiplex Assays Market Value Forecast by Country, 2016-2026
14.2.1. China
14.2.2. India
14.2.3. Japan
14.2.4. Australia
14.2.5. Rest of Asia Pacific
14.3. Asia Pacific Multiplex Assays Market Value Forecast, by Product, 2016-2026
14.3.1. Instruments
14.3.2. Consumables
14.3.2.1. Reagents & Kits
14.3.2.2. Micropipettes & Microplates
14.3.2.3. Others
14.3.3. Software
14.4. Asia Pacific Multiplex Assays Market Value Forecast, by Technology, 2016-2026
14.4.1. Multiplex RT-PCR
14.4.2. Flow Cytometry
14.4.3. Luminescence
14.4.4. Fluorescence
14.4.5. Others
14.5. Asia Pacific Multiplex Assays Market Value Forecast, by Type, 2016-2026
14.5.1. Protein
14.5.1.1. Planar
14.5.1.2. Bead-based
14.5.2. Nucleic Acid
14.5.2.1. Planar
14.5.2.2. Bead-based
14.5.3. Cell
14.6. Asia Pacific Multiplex Assays Market Value Forecast, by Application, 2016-2026
14.6.1. Research & Development
14.6.1.1. Drug Discovery & Research
14.6.1.2. Biomarker Research & Application
14.6.2. Diagnosis
14.6.2.1. Infectious Diseases
14.6.2.2. Autoimmune Diseases
14.6.2.3. Cancer
14.6.2.4. Cardiovascular Diseases
14.6.2.5. Neuro-endocrine Diseases
14.6.2.6. Others
14.6.3. Others
14.7. Asia Pacific Multiplex Assays Market Value Forecast, by End-user, 2016-2026
14.7.1. Academic & Research Centers
14.7.2. Biotechnology & Biopharmaceutical Companies
14.7.3. Diagnostic Centers
14.7.4. Hospitals
14.7.5. Others
14.8. Asia Pacific Multiplex Assays Market Attractiveness
14.8.1. By Country
14.8.2. By Product
14.8.3. By Technology
14.8.4. By Type
14.8.5. By Application
14.8.6. By End-user

15. Latin America Multiplex Assays Market Analysis
15.1. Key Findings
15.2. Latin America Multiplex Assays Market Value Forecast by Country, 2016-2026
15.2.1. Brazil
15.2.2. Mexico
15.2.3. Rest of Latin America
15.3. Latin America Multiplex Assays Market Value Forecast, by Product, 2016-2026
15.3.1. Instruments
15.3.2. Consumables
15.3.2.1. Reagents & Kits
15.3.2.2. Micropipettes & Microplates
15.3.2.3. Others
15.3.3. Software
15.4. Latin America Multiplex Assays Market Value Forecast, by Technology, 2016-2026
15.4.1. Multiplex RT-PCR
15.4.2. Flow Cytometry
15.4.3. Luminescence
15.4.4. Fluorescence
15.4.5. Others
15.5. Latin America Multiplex Assays Market Value Forecast, by Type, 2016-2026
15.5.1. Protein
15.5.1.1. Planar
15.5.1.2. Bead-based
15.5.2. Nucleic Acid
15.5.2.1. Planar
15.5.2.2. Bead-based
15.5.3. Cell
15.6. Latin America Multiplex Assays Market Value Forecast, by Application, 2016-2026
15.6.1. Research & Development
15.6.1.1. Drug Discovery & Research
15.6.1.2. Biomarker Research & Application
15.6.2. Diagnosis
15.6.2.1. Infectious Diseases
15.6.2.2. Autoimmune Diseases
15.6.2.3. Cancer
15.6.2.4. Cardiovascular Diseases
15.6.2.5. Neuro-endocrine Diseases
15.6.2.6. Others
15.6.3. Others
15.7. Latin America Multiplex Assays Market Value Forecast, by End-user, 2016-2026
15.7.1. Academic & Research Centers
15.7.2. Biotechnology & Biopharmaceutical Companies
15.7.3. Diagnostic Centers
15.7.4. Hospitals
15.7.5. Others
15.8. Latin America Multiplex Assays Market Attractiveness
15.8.1. By Country
15.8.2. By Product
15.8.3. By Technology
15.8.4. By Type
15.8.5. By Application
15.8.6. By End-user

16. Middle East & Africa Multiplex Assays Market Analysis
16.1. Key Findings
16.2. Middle East & Africa Multiplex Assays Market Value Forecast by Country, 2016-2026
16.2.1. GCC Countries
16.2.2. Israel
16.2.3. South Africa
16.2.4. Rest of Middle East & Africa
16.3. Middle East & Africa Multiplex Assays Market Value Forecast, by Product, 2016-2026
16.3.1. Instruments
16.3.2. Consumables
16.3.2.1. Reagents & Kits
16.3.2.2. Micropipettes & Microplates
16.3.2.3. Others
16.3.3. Software
16.4. Middle East & Africa Multiplex Assays Market Value Forecast, by Technology, 2016-2026
16.4.1. Multiplex RT-PCR
16.4.2. Flow Cytometry
16.4.3. Luminescence
16.4.4. Fluorescence
16.4.5. Others
16.5. Middle East & Africa Multiplex Assays Market Value Forecast, by Type, 2016-2026
16.5.1. Protein
16.5.1.1. Planar
16.5.1.2. Bead-based
16.5.2. Nucleic Acid
16.5.2.1. Planar
16.5.2.2. Bead-based
16.5.3. Cell
16.6. Middle East & Africa Multiplex Assays Market Value Forecast, by Application, 2016-2026
16.6.1. Research & Development
16.6.1.1. Drug Discovery & Research
16.6.1.2. Biomarker Research & Application
16.6.2. Diagnosis
16.6.2.1. Infectious Diseases
16.6.2.2. Autoimmune Diseases
16.6.2.3. Cancer
16.6.2.4. Cardiovascular Diseases
16.6.2.5. Neuro-endocrine Diseases
16.6.2.6. Others
16.6.3. Others
16.7. Middle East & Africa Multiplex Assays Market Value Forecast, by End-user, 2016-2026
16.7.1. Academic & Research Centers
16.7.2. Biotechnology & Biopharmaceutical Companies
16.7.3. Diagnostic Centers
16.7.4. Hospitals
16.7.5. Others
16.8. Middle East & Africa Multiplex Assays Market Attractiveness
16.8.1. By Country
16.8.2. By Product
16.8.3. By Technology
16.8.4. By Type
16.8.5. By Application
16.8.6. By End-user

17. Competitive Landscape
17.1. Competition Matrix
17.2. Company Profiles
17.2.1. Luminex Corporation
17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.1.2. Financial Overview
17.2.1.3. Product Portfolio
17.2.1.4. SWOT Analysis
17.2.1.5. Strategic Overview
17.2.2. Thermo Fisher Scientific, Inc.
17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.2.2. Financial Overview
17.2.2.3. Product Portfolio
17.2.2.4. SWOT Analysis
17.2.2.5. Strategic Overview
17.2.3. Seegene, Inc.
17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.3.2. Financial Overview
17.2.3.3. Product Portfolio
17.2.3.4. SWOT Analysis
17.2.3.5. Strategic Overview
17.2.4. Meso Scale Diagnostics, LLC.
17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.4.2. Product Portfolio
17.2.4.3. SWOT Analysis
17.2.4.4. Strategic Overview
17.2.5. Abcam plc
17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.5.2. Financial Overview
17.2.5.3. Product Portfolio
17.2.5.4. SWOT Analysis
17.2.5.5. Strategic Overview
17.2.6. Bio-Rad Laboratories, Inc.
17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.6.2. Financial Overview
17.2.6.3. Product Portfolio
17.2.6.4. SWOT Analysis
17.2.6.5. Strategic Overview
17.2.7. QIAGEN N.V.
17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.7.2. Financial Overview
17.2.7.3. Product Portfolio
17.2.7.4. SWOT Analysis
17.2.7.5. Strategic Overview
17.2.8. Merck KGaA
17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.8.2. Financial Overview
17.2.8.3. Product Portfolio
17.2.8.4. SWOT Analysis
17.2.8.5. Strategic Overview
17.2.9. Quansys Biosciences
17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.9.2. Product Portfolio
17.2.9.3. SWOT Analysis
17.2.10. Illumina, Inc.
17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.10.2. Financial Overview
17.2.10.3. Product Portfolio
17.2.10.4. SWOT Analysis
17.2.10.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll